CULLINAN THERAPEUTICS INC. - COMMON STOCK
12.65
25-十一月-24 13:08:15
15 分钟延时
股票
+0.11
+0.88%
今日范围
12.33 - 13.02
ISIN
N/A
来源
NASDAQ
-
Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting
26 5月 2022 07:45:00 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference
19 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports First Quarter 2022 Financial Results
16 5月 2022 05:45:00 条件 Nasdaq GlobeNewswire
-
12 5月 2022 01:00:00 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 5月 2022 16:10:24 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences
05 4月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 4月 2022 15:34:22 条件 Nasdaq GlobeNewswire
-
28 3月 2022 15:01:00 条件 Nasdaq GlobeNewswire
-
17 3月 2022 06:08:06 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Host CLN-081 Regulatory Update Webinar on March 28, 2022
17 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Present at the Barclays Global Healthcare Conference
09 3月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
08 3月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Present at SVB Leerink’s 11th Annual Global Healthcare Conference
07 2月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
10 1月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Present at Upcoming Virtual Investor Conferences
05 1月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
04 1月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology Announces Updated Phase 1/2a Data for CLN-081 in NSCLC EGFR Exon 20 Patients
16 12月 2021 05:30:00 条件 Nasdaq GlobeNewswire
-
Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients
13 12月 2021 06:00:00 条件 Nasdaq GlobeNewswire